Viewing Study NCT03950427



Ignite Creation Date: 2024-05-06 @ 1:11 PM
Last Modification Date: 2024-10-26 @ 1:10 PM
Study NCT ID: NCT03950427
Status: RECRUITING
Last Update Posted: 2023-09-18
First Post: 2019-05-13

Brief Title: PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Study Overview

Official Title: PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
Status: RECRUITING
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PARQuit
Brief Summary: This is a research study about a smoking cessation program tailored for adults with serious mental illness SMI The program uses a Videogame-based Physical VIP activity smoking cessation counseling and medication bupropion
Detailed Description: The purpose of this study is to learn more about how adults with serious mental illness respond to a smoking cessation program combining a game-based Physical activity counseling for smoking cessation and a medication bupropion or NRT for smoking cessation

Study participants will receive counseling to quit smoking and a medication to help decrease cravings and withdrawal Additionally participants will be randomly selected to participate in either a game-based physical activity group or a game group where the participants sit to play the games

Participants will be in this study for 12 weeks total There are 3 assessment visits 2 hours each at the beginning of the study 6 weeks after starting and at the end of the 12 weeks There will be 8 30- minute counseling sessions during the 12 weeks The hour-long videogame groups will be held 3 times a week for 12 weeks 36 sessions Upon completion of the 12-week program there will be a 1-2 hour group interview The total time commitment is 48 hours over the course of the 12-week study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2022-02281 REGISTRY NCI Clinical Trials Reporting Program CTRP None
22637 OTHER None None